Dermapharm Holding SE

XETRA:DMP

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DMP's stock price target?

Price Target

57.63 EUR

According to Wall Street analysts, the average 1-year price target for DMP is 57.63 EUR with a low forecast of 48.48 EUR and a high forecast of 68.25 EUR.

What is Dermapharm Holding SE's Revenue forecast?

Projected CAGR

4%

For the last 8 years the compound annual growth rate for Dermapharm Holding SE's revenue is 14%. The projected CAGR for the next 3 years is 4%.

What is Dermapharm Holding SE's Operating Income forecast?

Projected CAGR

8%

For the last 8 years the compound annual growth rate for Dermapharm Holding SE's operating income is 14%. The projected CAGR for the next 3 years is 8%.

What is Dermapharm Holding SE's Net Income forecast?

Projected CAGR

31%

For the last 8 years the compound annual growth rate for Dermapharm Holding SE's net income is 22%. The projected CAGR for the next 3 years is 31%.